Horizon Financial Statements From 2010 to 2024
| HZNPDelisted Stock | USD 116.30 0.00 0.00% |
Check Horizon Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Horizon main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Horizon financial statements analysis is a perfect complement when working with Horizon Pharma Valuation or Volatility modules.
Horizon |
Horizon Pharma PLC Company Profit Margin Analysis
Horizon Pharma's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Horizon Pharma Profit Margin | 0.12 % |
Most of Horizon Pharma's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Horizon Pharma PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Horizon Pharma PLC has a Profit Margin of 0.1202%. This is 101.07% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The profit margin for all United States stocks is 109.46% lower than that of the firm.
Horizon Pharma PLC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Horizon Pharma's current stock value. Our valuation model uses many indicators to compare Horizon Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Horizon Pharma competition to find correlations between indicators driving Horizon Pharma's intrinsic value. More Info.Horizon Pharma PLC is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies reporting about 0.52 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Horizon Pharma PLC is roughly 1.92 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Horizon Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Horizon Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Horizon Pharma's earnings, one of the primary drivers of an investment's value.About Horizon Pharma Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Horizon Pharma income statement, its balance sheet, and the statement of cash flows. Horizon Pharma investors use historical funamental indicators, such as Horizon Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Horizon Pharma investors may use each financial statement separately, they are all related. The changes in Horizon Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Horizon Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Horizon Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Horizon Pharma. Please read more on our technical analysis and fundamental analysis pages.
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland with additional offices in Deerfield, Illinois Chicago, Illinois Lake Forest, Illinois South San Francisco, California Washington, D.C. Gaithersburg, Maryland Rockville, Maryland and Mannheim, Germany. Horizon Therapeutics is traded on NASDAQ Exchange in the United States.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Horizon Stock
If you are still planning to invest in Horizon Pharma PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Horizon Pharma's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |